Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study

Background/aims: Treatment of chronic HCV infection has become a priority in HIV+ patients, given the faster progression to end-stage liver disease. The primary endpoint of this study was to evaluate and compare antiviral efficacy of Peginterferon alpha 2a plus ribavirin in HIV-HCV co-infected an...

Full description

Bibliographic Details
Main Authors: D Genné, J Borovicka, A Cerny, C Chuard, V Dutoit, R Malinverni, B Müllhaupt, M Monnat, F Negro, C Oneta, JP Chave, JF Dufour, JJ Gonvers, MH Heim
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2010-07-01
Series:Swiss Medical Weekly
Subjects:
Hepatitis C
HIV
Peginterferon
Ribavirin
Treatment
Online Access:https://www.smw.ch/index.php/smw/article/view/1158

Internet

https://www.smw.ch/index.php/smw/article/view/1158

Similar Items